The US is recommending a pause in administration of the single-dose Johnson & Johnson COVID-19 vaccine to research studies of probably harmful blood clots.
In a joint assertion Tuesday, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) mentioned it was investigating clots in six ladies within the days after vaccination together with diminished platelet counts. More than 68 million doses of the JJ vaccine have been administered within the US.
US federal distribution channels, together with mass vaccination websites, will pause the usage of the JJ shot and states and different suppliers are anticipated to observe.
CDCs Advisory Committee on Immunization Practices will meet Wednesday to debate the instances and the FDA has additionally launched an investigation of the instances.
“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr Anne Schuchat Principal Deputy Director of the CDC and Dr Peter Marks director of the FDAs Center for Biologics Evaluation and Research mentioned in a joint assertion.
